Ερευνητικό Ινστιτούτο Επιδημιολογίας και Μικροβιολογίας Γκαμαλέγια (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ερευνητικό Ινστιτούτο Επιδημιολογίας και Μικροβιολογίας Γκαμαλέγια" in Greek language version.

refsWebsite

Global rank Greek rank

7worldcat.org

5^th place

8^th place

5doi.org

2^nd place

3^rd place

5nih.gov

4^th place

3gamaleya.org

low place

3thelancet.com

2,393^rd place

1,822^nd place

2nytimes.com

7^th place

29^th place

2clinicaltrials.gov

5,225^th place

7,320^th place

1tass.com

1,763^rd place

4,617^th place

1actanaturae.ru

low place

1who.int

195^th place

72^nd place

1wipo.int

1,462^nd place

1,546^th place

1dailysabah.com

2,228^th place

1,984^th place

1reuters.com

49^th place

98^th place

actanaturae.ru

Dolzhikova, I. V.; В, Должикова И.; Tokarskaya, E. A.; A, Токарская E.; Dzharullaeva, A. S.; Ш, Джаруллаева A.; Tukhvatulin, A. I.; И, Тухватулин A. και άλλοι. (2017-09-15). «Virus-Vectored Ebola Vaccines» (στα αγγλικά). Acta Naturae 9 (3): 4–11. doi:10.32607/20758251-2017-9-3-4-11. ISSN 2075-8251. http://actanaturae.ru/2075-8251/article/view/10364.

clinicaltrials.gov

«International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi - Full Text View - ClinicalTrials.gov» (στα αγγλικά). https://clinicaltrials.gov/ct2/show/NCT03072030?term=GamEvac&draw=2&rank=1. Ανακτήθηκε στις 2021-03-21.
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation; CRO: Crocus Medical BV (2021-01-20). Randomized Double-blind Placebo-controlled Multi-center Clinical Trial in Parallel Assignment of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine in SARS-СoV-2 Infection Prophylactic Treatment. clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT04530396.

dailysabah.com

DPA, German Press Agency- (13 Ιουνίου 2020). «Russia plans to start producing coronavirus vaccine in September». Daily Sabah (στα Αγγλικά). Ανακτήθηκε στις 21 Μαρτίου 2021.

doi.org

dx.doi.org

Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L. και άλλοι. (2021-02-20). «Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia» (στα English). The Lancet 397 (10275): 671–681. doi:10.1016/S0140-6736(21)00234-8. ISSN 0140-6736. PMID 33545094. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/abstract.
Dolzhikova, I. V.; В, Должикова И.; Tokarskaya, E. A.; A, Токарская E.; Dzharullaeva, A. S.; Ш, Джаруллаева A.; Tukhvatulin, A. I.; И, Тухватулин A. και άλλοι. (2017-09-15). «Virus-Vectored Ebola Vaccines» (στα αγγλικά). Acta Naturae 9 (3): 4–11. doi:10.32607/20758251-2017-9-3-4-11. ISSN 2075-8251. http://actanaturae.ru/2075-8251/article/view/10364.
Dolzhikova, I. V.; Zubkova, O. V.; Tukhvatulin, A. I.; Dzharullaeva, A. S.; Tukhvatulina, N. M.; Shcheblyakov, D. V.; Shmarov, M. M.; Tokarskaya, E. A. και άλλοι. (2017-02-02). «Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia». Human Vaccines & Immunotherapeutics 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMID 28152326. PMC 5360131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360131/.
Logunov, Denis Y.; Dolzhikova, Inna V.; Zubkova, Olga V.; Tukhvatulin, Amir I.; Shcheblyakov, Dmitry V.; Dzharullaeva, Alina S.; Grousova, Daria M.; Erokhova, Alina S. και άλλοι. (2020-09-26). «Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia» (στα English). The Lancet 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/abstract.
Jones, Ian; Roy, Polly (2021-02-20). «Sputnik V COVID-19 vaccine candidate appears safe and effective» (στα English). The Lancet 397 (10275): 642–643. doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. PMID 33545098. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract.

gamaleya.org

«Общая информация». gamaleya.org. Ανακτήθηκε στις 21 Μαρτίου 2021.
«История центра». gamaleya.org. Ανακτήθηκε στις 21 Μαρτίου 2021.
«Ebola». gamaleya.org. Ανακτήθηκε στις 21 Μαρτίου 2021.

nih.gov

ncbi.nlm.nih.gov

Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L. και άλλοι. (2021-02-20). «Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia» (στα English). The Lancet 397 (10275): 671–681. doi:10.1016/S0140-6736(21)00234-8. ISSN 0140-6736. PMID 33545094. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/abstract.
Dolzhikova, I. V.; Zubkova, O. V.; Tukhvatulin, A. I.; Dzharullaeva, A. S.; Tukhvatulina, N. M.; Shcheblyakov, D. V.; Shmarov, M. M.; Tokarskaya, E. A. και άλλοι. (2017-02-02). «Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia». Human Vaccines & Immunotherapeutics 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMID 28152326. PMC 5360131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360131/.
Logunov, Denis Y.; Dolzhikova, Inna V.; Zubkova, Olga V.; Tukhvatulin, Amir I.; Shcheblyakov, Dmitry V.; Dzharullaeva, Alina S.; Grousova, Daria M.; Erokhova, Alina S. και άλλοι. (2020-09-26). «Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia» (στα English). The Lancet 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/abstract.
Jones, Ian; Roy, Polly (2021-02-20). «Sputnik V COVID-19 vaccine candidate appears safe and effective» (στα English). The Lancet 397 (10275): 642–643. doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. PMID 33545098. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract.

pubmedcentral.nih.gov

Dolzhikova, I. V.; Zubkova, O. V.; Tukhvatulin, A. I.; Dzharullaeva, A. S.; Tukhvatulina, N. M.; Shcheblyakov, D. V.; Shmarov, M. M.; Tokarskaya, E. A. και άλλοι. (2017-02-02). «Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia». Human Vaccines & Immunotherapeutics 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMID 28152326. PMC 5360131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360131/.

nytimes.com

Corum, Jonathan; Zimmer, Carl. «How Gamaleya’s Vaccine Works» (στα αγγλικά). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2021/health/gamaleya-covid-19-vaccine.html. Ανακτήθηκε στις 2021-03-21.
Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. «Coronavirus Vaccine Tracker» (στα αγγλικά). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Ανακτήθηκε στις 2021-03-21.

reuters.com

Staff, Reuters (2021-01-14). «Russia to meet its Sputnik V vaccine export promises over next 6-9 months: RDIF chief» (στα αγγλικά). Reuters. https://www.reuters.com/article/us-health-coronavirus-russia-dmitriev-ex-idINKBN29J1GC. Ανακτήθηκε στις 2021-03-21.

tass.com

«COVID-19 vaccines by Gamaleya Center, Vektor are most promising». TASS. Ανακτήθηκε στις 21 Μαρτίου 2021.

thelancet.com

Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L. και άλλοι. (2021-02-20). «Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia» (στα English). The Lancet 397 (10275): 671–681. doi:10.1016/S0140-6736(21)00234-8. ISSN 0140-6736. PMID 33545094. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/abstract.
Logunov, Denis Y.; Dolzhikova, Inna V.; Zubkova, Olga V.; Tukhvatulin, Amir I.; Shcheblyakov, Dmitry V.; Dzharullaeva, Alina S.; Grousova, Daria M.; Erokhova, Alina S. και άλλοι. (2020-09-26). «Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia» (στα English). The Lancet 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/abstract.
Jones, Ian; Roy, Polly (2021-02-20). «Sputnik V COVID-19 vaccine candidate appears safe and effective» (στα English). The Lancet 397 (10275): 642–643. doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. PMID 33545098. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract.

who.int

«WHO | Safety of Ebola Virus Vaccines». WHO. Ανακτήθηκε στις 21 Μαρτίου 2021.

wipo.int

patentscope.wipo.int

Logunov, Denis Jurievich; Shmarov, Maksim Mikhailovich; Tutykhina, Irina Leonidovna; Zubkova, Olga Vadimovna; Scheblyakov, Dmitry Viktorovich; Lysenko, Andrey Aleksandrovich; Scherbinin, Dmitry Nikolaevich; Dolzhikova, Inna Vadimovna και άλλοι. (2016-08-18), Immunobiological Drug and Method for Using Same for Inducing Specific Immunity Against the Ebola Virus, https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016130047, ανακτήθηκε στις 2021-03-21

worldcat.org

Logunov, Denis Y.; Dolzhikova, Inna V.; Shcheblyakov, Dmitry V.; Tukhvatulin, Amir I.; Zubkova, Olga V.; Dzharullaeva, Alina S.; Kovyrshina, Anna V.; Lubenets, Nadezhda L. και άλλοι. (2021-02-20). «Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia» (στα English). The Lancet 397 (10275): 671–681. doi:10.1016/S0140-6736(21)00234-8. ISSN 0140-6736. PMID 33545094. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/abstract.
Corum, Jonathan; Zimmer, Carl. «How Gamaleya’s Vaccine Works» (στα αγγλικά). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2021/health/gamaleya-covid-19-vaccine.html. Ανακτήθηκε στις 2021-03-21.
Zimmer, Carl; Corum, Jonathan; Wee, Sui-Lee. «Coronavirus Vaccine Tracker» (στα αγγλικά). The New York Times. ISSN 0362-4331. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Ανακτήθηκε στις 2021-03-21.
Dolzhikova, I. V.; В, Должикова И.; Tokarskaya, E. A.; A, Токарская E.; Dzharullaeva, A. S.; Ш, Джаруллаева A.; Tukhvatulin, A. I.; И, Тухватулин A. και άλλοι. (2017-09-15). «Virus-Vectored Ebola Vaccines» (στα αγγλικά). Acta Naturae 9 (3): 4–11. doi:10.32607/20758251-2017-9-3-4-11. ISSN 2075-8251. http://actanaturae.ru/2075-8251/article/view/10364.
Dolzhikova, I. V.; Zubkova, O. V.; Tukhvatulin, A. I.; Dzharullaeva, A. S.; Tukhvatulina, N. M.; Shcheblyakov, D. V.; Shmarov, M. M.; Tokarskaya, E. A. και άλλοι. (2017-02-02). «Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia». Human Vaccines & Immunotherapeutics 13 (3): 613–620. doi:10.1080/21645515.2016.1238535. ISSN 2164-5515. PMID 28152326. PMC 5360131. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360131/.
Logunov, Denis Y.; Dolzhikova, Inna V.; Zubkova, Olga V.; Tukhvatulin, Amir I.; Shcheblyakov, Dmitry V.; Dzharullaeva, Alina S.; Grousova, Daria M.; Erokhova, Alina S. και άλλοι. (2020-09-26). «Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia» (στα English). The Lancet 396 (10255): 887–897. doi:10.1016/S0140-6736(20)31866-3. ISSN 0140-6736. PMID 32896291. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/abstract.
Jones, Ian; Roy, Polly (2021-02-20). «Sputnik V COVID-19 vaccine candidate appears safe and effective» (στα English). The Lancet 397 (10275): 642–643. doi:10.1016/S0140-6736(21)00191-4. ISSN 0140-6736. PMID 33545098. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/abstract.